Woman and Man | Between 18 years et 75 years
- | Country :
- France
- | organs :
- Myélomes
- | Specialty :
- Thérapies Ciblées
Extract
Randomised Phase II Study Evaluating the Anti-tumour Activity, Safety and Pharmacology of Two Dose Regimens of IPH2101, a Human Monoclonal Anti-KIR Antibody, in Patients With Multiple Myeloma in Stable Partial Response After a First Line Therapy
Scientific Abstract
en cours d'intégration;